My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 150

    1.

    Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations: response to Equitani et al.

    Valenti L, Dongiovanni P, Fracanzani AL, Fargion S.

    Diabetes Care. 2008 Mar;31(3):e18; author reply e19. No abstract available. PMID: 18308681 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations.

    Equitani F, Fernandez-Real JM, Menichella G, Koch M, Calvani M, Nobili V, Mingrone G, Manco M.

    Diabetes Care. 2008 Jan;31(1):3-8. Epub 2007 Oct 24.PMID: 17959863 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Re: Brunt et. al.--Histological evaluation of iron in liver biopsies: relationship to HFE mutations.

    Mattman A, Huntsman D, Lockitch G, Owen D.

    Am J Gastroenterol. 2001 Mar;96(3):926. No abstract available. PMID: 11280588 [PubMed - indexed for MEDLINE]Related articles

    4.

    Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.

    Loria P, Lonardo A, Carulli N.

    Hepatology. 2004 Jun;39(6):1748; author reply 1749. No abstract available. PMID: 15185321 [PubMed - indexed for MEDLINE]Related articles

    5.

    Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime?

    Bhattacharya R, Kowdley KV.

    Gastroenterology. 2003 Aug;125(2):615-6; discussion 617. No abstract available. PMID: 12891567 [PubMed - indexed for MEDLINE]Related articles

    6.

    HFE mutations in insulin resistance-associated hepatic iron overload.

    Guillygomarc'h A, Mendler MH, Moirand R, Jouanolle AM, David V, Deugnier Y.

    J Hepatol. 2000 Sep;33(3):515-6. No abstract available. PMID: 11020014 [PubMed - indexed for MEDLINE]Related articles

    7.

    Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen?

    Ioannou GN, Kowdley KV.

    Clin Gastroenterol Hepatol. 2003 Jul;1(4):246-8. No abstract available. PMID: 15017663 [PubMed - indexed for MEDLINE]Related articles

    8.

    More clues to the relationship between hepatic iron and steatosis: An association with insulin resistance?

    Macdonald GA, Powell LW.

    Gastroenterology. 1999 Nov;117(5):1241-4. Review. No abstract available. PMID: 10535890 [PubMed - indexed for MEDLINE]Related articles

    9.

    Hypoxic response of iron absorption is not affected by the Hfe gene knock-out in mice.

    Laftah AH, Simpson RJ, Beaumont N, Bahram S, Schümann K, Srai SK.

    Br J Haematol. 2003 Oct;123(1):170-2.PMID: 14510961 [PubMed - indexed for MEDLINE]Related articles

    10.

    HFE mutations and Alzheimer's disease.

    Connor JR, Lee SY.

    J Alzheimers Dis. 2006 Nov;10(2-3):267-76. Review.PMID: 17119292 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Non-alcoholic fatty liver disease, serum iron indexes and iron concentration in the liver.]

    Fernández Salazar LI, Aller de la Fuente R, Velayos Jiménez B, González Hernández JM.

    Gastroenterol Hepatol. 2005 Jun-Jul;28(6):364. Spanish. No abstract available. PMID: 15989823 [PubMed - indexed for MEDLINE]Related articles

    12.

    [HFE gene mutations and risk of hepatocellular carcinoma]

    Solís Herruzo JA, Solís Muñoz P.

    Rev Esp Enferm Dig. 2007 Jul;99(7):369-75. Review. Spanish. No abstract available. PMID: 17973579 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Hfe acts in hepatocytes to prevent hemochromatosis.

    Vujić Spasić M, Kiss J, Herrmann T, Galy B, Martinache S, Stolte J, Gröne HJ, Stremmel W, Hentze MW, Muckenthaler MU.

    Cell Metab. 2008 Feb;7(2):173-8.PMID: 18249176 [PubMed - indexed for MEDLINE]Related articles

    14.

    HFE gene in primary and secondary hepatic iron overload.

    Sebastiani G, Walker AP.

    World J Gastroenterol. 2007 Sep 21;13(35):4673-89. Review.PMID: 17729389 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of iron and HFE mutations on response to therapy in chronic hepatitis C: an ironic interaction?

    Alexander J, Kowdley KV.

    Gastroenterology. 2006 Nov;131(5):1635-8. No abstract available. PMID: 17067603 [PubMed - indexed for MEDLINE]Related articles

    16.

    Measurement of liver iron content by magnetic resonance imaging in 20 patients with overt porphyria cutanea tarda before phlebotomy therapy: a prospective study.

    Dereure O, Jumez N, Bessis D, Gallix B, Guillot B.

    Acta Derm Venereol. 2008;88(4):341-5.PMID: 18709302 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hereditary hemochromatosis: pathophysiology, diagnosis, and management.

    Fowler C.

    Crit Care Nurs Clin North Am. 2008 Jun;20(2):191-201, vi. Review.PMID: 18424348 [PubMed - indexed for MEDLINE]Related articles

    18.

    Enrichment of HFE mutations in Swedish patients with familial and sporadic form of porphyria cutanea tarda.

    Harper P, Floderus Y, Holmström P, Eggertsen G, Gåfvels M.

    J Intern Med. 2004 Jun;255(6):684-8. No abstract available. PMID: 15147533 [PubMed - indexed for MEDLINE]Related articles

    19.

    Nash, insulin resistance and iron.

    Machado M, Cortez-Pinto H.

    Liver Int. 2006 Dec;26(10):1159-62. No abstract available. PMID: 17105580 [PubMed - indexed for MEDLINE]Related articles

    20.

    High prevalence of HFE gene mutations in hemodialysis patients.

    Mennella G, Valverde S, Forzan S, Fezzi M, Munaretto G, Gessoni G.

    Minerva Urol Nefrol. 2008 Jun;60(2):81-4.PMID: 18500222 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity